Multiplex genotyping of 1107 SNPs from 232 candidate genes identified an association between IL1A polymorphism and breast cancer risk

Oncology Reports

Volumn 23, Issue 3, 2010, Pages 763-769

  Han, Wonshik ^a   Kang, So Young ^a   Kang, Daehee ^a   Park, Sue K ^a   Lee, Ji Young ^a   Kim, Ho ^a   Park, Ae Kyung ^a   Noh, Dong Young ^a  

^a Seoul National University College of Medicine   (South Korea)

Author keywords

Breast cancer; IL1A; Multiplex genotyping; Polymorphism; Risk

Indexed keywords

CYTOKINE; INTERCELLULAR ADHESION MOLECULE 1; INTERLEUKIN 1 RECEPTOR BLOCKING AGENT; INTERLEUKIN 12P35; INTERLEUKIN 1ALPHA; INTERLEUKIN 5; PEPTIDE HORMONE; PROTEIN BCL 2; PROTEIN INSL3; PROTEIN TNFRSF10B; PROTEIN TNFRSF1B; PROTEIN TNFSF9; UNCLASSIFIED DRUG;

3' UNTRANSLATED REGION; ADULT; ALCOHOL CONSUMPTION; ALLELE; ARTICLE; BREAST CANCER; CANCER RISK; CONTROLLED STUDY; EXON; FAMILY HISTORY; FEMALE; GENE; GENE IDENTIFICATION; GENETIC VARIABILITY; GENOTYPE; GPX3 GENE; HAPLOTYPE; HETEROZYGOSITY; HOMOZYGOSITY; HUMAN; INTRON; LOC96597 GENE; MAJOR CLINICAL STUDY; PRIORITY JOURNAL; PROMOTER REGION; SINGLE NUCLEOTIDE POLYMORPHISM;

ADULT; AGED; BREAST NEOPLASMS; FEMALE; GENOTYPE; HAPLOTYPES; HUMANS; INTERCELLULAR ADHESION MOLECULE-1; INTERLEUKIN-1ALPHA; MIDDLE AGED; POLYMORPHISM, SINGLE NUCLEOTIDE; RISK FACTORS;

EID: 77349092316     PISSN: 1021335X     EISSN: 17912431     Source Type: Journal    
DOI: 10.3892/or-00000696     Document Type: Article

References (36)

1. Bennett IC, Gattas M and Teh BT: The management of familial breast cancer. Breast 9: 247-263, 2000.
2. Garcia-Closas M and Chanock S: Genetic susceptibility loci for breast cancer by estrogen receptor status. Clin Cancer Res 14: 8000-8009, 2008.
3. Garcia-Closas M, Malats N, Real FX, et al: Large-scale evaluation of candidate genes identifies associations between VEGF polymorphisms and bladder cancer risk. PLoS Genet 3: e29, 2007.
4. Stacey SN, Manolescu A, Sulem P, et al: Common variants on chromosomes 2q35 and 16q12 confer susceptibility to estrogen receptor-positive breast cancer. Nat Genet 39: 865-869, 2007.
5. Sigurdson AJ, Bhatti P, Doody MM, et al: Polymorphisms in apoptosis- and proliferation-related genes, ionizing radiation exposure, and risk of breast cancer among US Radiologic Technologists. Cancer Epidemiol Biomarkers Prev 16: 2000-2007, 2007.
6. Lee KM, Park SK, Hamajima N, et al: Genetic polymorphisms of interleukin-1 beta (IL-1B) and IL-1 receptor antagonist (IL-1RN) and breast cancer risk in Korean women. Breast Cancer Res Treat 96: 197-202, 2006.
7. Hefler LA, Grimm C, Lantzsch T, et al: Interleukin-1 and interleukin-6 gene polymorphisms and the risk of breast cancer in caucasian women. Clin Cancer Res 11: 5718-5721, 2005.
8. Frank B, Hemminki K, Shanmugam KS, et al: Association of death receptor 4 haplotype 626C-683C with an increased breast cancer risk. Carcinogenesis 26: 1975-1977, 2005.
9. Crew KD, Gammon MD, Terry MB, et al: Genetic polymorphisms in the apoptosis-associated genes FAS and FASL and breast cancer risk. Carcinogenesis 28: 2548-2551, 2007.
10. Cox A, Dunning AM, Garcia-Closas M, et al: A common coding variant in CASP8 is associated with breast cancer risk. Nat Genet 39: 352-358, 2007.
11. Kammerer S, Roth RB, Reneland R, et al: Large-scale association study identifies ICAM gene region as breast and prostate cancer susceptibility locus. Cancer Res 64: 8906-8910, 2004.
12. Scola L, Vaglica M, Crivello A, et al: Cytokine gene polymorphisms and breast cancer susceptibility. Ann N Y Acad Sci 1089: 104-109, 2006.
13. Curran JE, Weinstein SR and Griffiths LR: Polymorphic variants of NFKB1 and its inhibitory protein NFKBIA, and their involvement in sporadic breast cancer. Cancer Lett 188: 103-107, 2002.
14. Goode EL, Ulrich CM and Potter JD: Polymorphisms in DNA repair genes and associations with cancer risk. Cancer Epidemiol Biomarkers Prev 11: 1513-1530, 2002.
15. Packer BR, Yeager M, Burdett L, et al: SNP500Cancer: a public resource for sequence validation, assay development, and frequency analysis for genetic variation in candidate genes. Nucleic Acids Res 34: D617-D621, 2006.
16. Cox DR and Hinkley DV: Theoretical Statistics. Chapman and Hall, London, 1974.
17. Shaffer JP: Controlling the false discovery rate with constraints: the Newman-Keuls test revisited. Biom J 49: 136-143, 2007.
18. Nicolini A, Carpi A and Rossi G: Cytokines in breast cancer. Cytokine Growth Factor Rev 17: 325-337, 2006.
19. Pantschenko AG, Pushkar I, Anderson KH, et al: The interleukin-1 family of cytokines and receptors in human breast cancer: implications for tumor progression. Int J Oncol 23: 269-284, 2003.
20. Singer CF, Kronsteiner N, Hudelist G, et al: Interleukin 1 system and sex steroid receptor expression in human breast cancer: interleukin 1alpha protein secretion is correlated with malignant phenotype. Clin Cancer Res 9: 4877-4883, 2003.
21. Miller LJ, Kurtzman SH, Anderson K, et al: Interleukin-1 family expression in human breast cancer: interleukin-1 receptor antagonist. Cancer Invest 18: 293-302, 2000.
22. Balasubramanian SP, Azmy IA, Higham SE, et al: Interleukin gene polymorphisms and breast cancer: a case control study and systematic literature review. BMC Cancer 6: 188, 2006.
23. Ito LS, Iwata H, Hamajima N, et al: Significant reduction in breast cancer risk for Japanese women with interleukin 1B -31 CT/TT relative to CC genotype. Jpn J Clin Oncol 32: 398-402, 2002.
24. Kristensen VN, Edvardsen H, Tsalenko A, et al: Genetic variation in putative regulatory loci controlling gene expression in breast cancer. Proc Natl Acad Sci USA 103: 7735-7740, 2006.
25. Sims AM, Timms AE, Bruges-Armas J, et al: Prospective metaanalysis of IL-1 gene complex polymorphisms confirms associations with ankylosing spondylitis. Ann Rheum Dis 67: 1305-1309, 2008.
26. Nicklin MJ, Weith A and Duff GW: A physical map of the region encompassing the human interleukin-1 alpha, interleukin-1 beta, and interleukin-1 receptor antagonist genes. Genomics 19: 382-384, 1994.
27. Cox DG, Hankinson SE and Hunter DJ: Polymorphisms in the ICAM gene locus are not associated with breast cancer Risk. Cancer Epidemiol Biomarkers Prev 15: 178-179, 2006.
28. Martinez-Ferrandis JI, Rodriguez-Lopez R, Milne RL, et al: Polymorphisms in TRAIL receptor genes and risk of breast cancer in Spanish women. Cancer Biomark 3: 89-93, 2007.
29. Kim SU, Park SK, Yoo KY, et al: XRCC1 genetic polymorphism and breast cancer risk. Pharmacogenetics 12: 335-338, 2002.
30. Lee KM, Choi JY, Kang C, et al: Genetic polymorphisms of selected DNA repair genes, estrogen and progesterone receptor status, and breast cancer risk. Clin Cancer Res 11: 4620-4626, 2005.
31. Lee SA, Lee KM, Park WY, et al: Obesity and genetic polymorphism of ERCC2 and ERCC4 as modifiers of risk of breast cancer. Exp Mol Med 37: 86-90, 2005.
32. Lee SA, Lee KM, Park SK, et al: Genetic polymorphism of XRCC3 Thr241Met and breast cancer risk: case-control study in Korean women and meta-analysis of 12 studies. Breast Cancer Res Treat 103: 71-76, 2007.
33. Lee KM, Park SK, Hamajima N, et al: Genetic polymorphisms of TGF-beta1 & TNF-beta and breast cancer risk. Breast Cancer Res Treat 90: 149-155, 2005.
34. Han S, Lee KM, Choi JY, et al: CASP8 polymorphisms, estrogen and progesterone receptor status, and breast cancer risk. Breast Cancer Res Treat 110: 387-393, 2008.
35. Easton DF, Pooley KA, Dunning AM, et al: Genome-wide association study identifies novel breast cancer susceptibility loci. Nature 447: 1087-1093, 2007.
36. Hunter DJ, Kraft P, Jacobs KB, et al: A genome-wide association study identifies alleles in FGFR2 associated with risk of sporadic postmenopausal breast cancer. Nat Genet 39: 870-874, 2007.